IP Library Granted Patent US 8,512,548
Granted Patent B2
US 8,512,548 · App. 13/601,586 · Granted Aug 20, 2013

Measurement and uses of oxidative status

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,548
App. No.
13/601,586
Granted
Aug 20, 2013
Kind
B2
Abstract

The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill or who are critically ill, patients who have an infection, and patients suspected of having a myocardial infarction (MI) or who have had an MI. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.

Claims (11)

1. A method of evaluating a patient having a condition associated with oxidative stress in a hospital prior to discharge to determine whether the patient should be discharged from the hospital, wherein the patient has an elevated oxidation-reduction potential (ORP) relative to normal patients, the method comprising the following steps:

a. measuring the oxidation-reduction potential (ORP) of a body fluid of the patient, wherein the body fluid is plasma;

b. determining if the ORP is significantly different than the ORP of the same body fluid from normals; and

c. discharging the patient from the hospital if the ORP is not significantly elevated compared to normals.

2. The method of claim 1 wherein the ORP is measured within the 24 hours prior to discharge of the patient from the hospital.

3. The method of claim 1 , wherein the ORP is measured once per day or a plurality of times per day prior to discharge.

4. The method of claim 1 , wherein the step of measuring the ORP comprises contacting an ORP electrode or redox electrode with the body fluid or tissue of the patient.

5. A method of evaluating a patient having a condition associated with oxidative stress in a hospital prior to discharge to determine whether the patient should be discharged from the hospital, wherein the patient has an elevated oxidation-reduction potential (ORP) relative to normal patients, the method comprising the following steps:

a. contacting an oxidation-reduction potential (ORP) electrode or a redox electrode with a body fluid of the patient to measure the ORP of the body fluid within the 24 hours prior to discharge of the patient from the hospital, wherein the body fluid is plasma;

b. determining if the ORP is significantly elevated compared to the ORP of the same body fluid from normals; and

c. discharging the patient from the hospital if the ORP is not significantly elevated compared to normals.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: AYTU BIOSCIENCE, INC.
To: CAERUS BIOTECHNOLOGIES
Reel/Frame 057716/0502 →
MERGER Recorded Aug 20, 2015
From: LUOXIS DIAGNOSTICS, INC.
To: ROSEWIND CORPORATION
Reel/Frame 036380/0283 →
CERTIFICATES OF CONVERSION AND INCORPORATION Recorded Aug 20, 2015
From: ROSEWIND CORPORATION
To: AYTU BIOSCIENCE, INC.
Reel/Frame 036400/0479 →